Target intelligence / Profile preview

RNA, U5B small nuclear 2, pseudogene (RNU5B-2P)

Target
RNU5B-2P
Molecular classification
Other (pseudogene)
01

Overview

RNU5B-2P is a pseudogene annotated in the human genome. It shares sequence similarity with functional snRNAs of the U5 family, which are essential RNA components of the spliceosome responsible for pre-mRNA splicing. Unlike its functional paralogs (such as RNU5B-1), RNU5B-2P does not produce a stable or functional RNA product and is considered an inactive genomic sequence. There are no established molecular functions, disease associations, nor pharmacological interventions related to RNU5B-2P. Current research and disease roles focus on active snRNAs (such as RNU5B-1, RNU5A-1, or RNU4-2), which when mutated can cause neurodevelopmental disorders, but RNU5B-2P itself is not implicated in these processes[1][3][4]. If structured or actionable information is needed about spliceosomal snRNA drug targets or disease genes, refer to active genes in the U5 family (e.g., RNU5B-1).

02

Mechanism of action

None (no known mechanism of action for drugs, as it is not targeted)

03

Biological functions

None established (as a pseudogene, it lacks a known biological function and does not participate in cellular processes)
04

Disease associations

None directly attributed to RNU5B-2P. Pathogenic roles ascribed to rare variants in its functional relatives (such as RNU5B-1) but not for RNU5B-2P itself
05

Safety considerations

None (no safety concerns, as it is not a target for therapy or modulation)
06

Interacting drugs

None (no drugs interact with RNU5B-2P; pseudogenes are not pharmacological targets)
07

Biomarkers

None (RNU5B-2P is not used as a biomarker for disease or patient stratification)

Beyond the preview

Go deeper on RNA, U5B small nuclear 2, pseudogene (RNU5B-2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U5B small nuclear 2, pseudogene (RNU5B-2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call